wondered whether the treatment could have had anything to do with the onset of the pneumonia. The figures given in regard to Case X seemed quite extraordinary; there was a doubling of the number of red corpuscles in about a week, which, of course, would be admitted to be absolutely phenomenal. When participating in the recent discussion held by this Section on the treatment of cancer by other than operative means, he referred to the fact that Dr. Bernstein and he had made use of salvarsan in cases of malignant disease, but in not one of them could an improvement be attributed to the use of the drug. From what Mr. McDonagh had said he could only assume that they were not cases in which there was any underlying strain of syphilis. Two years ago there were threatenings of a small-pox epidemic in London, therefore, having learnt that Haller had recorded certain cases of the disease as having benefited by the drug, he obtained a grant from the Royal Society, intending to make trial of it in the treatment of small-pox. But the investigation was cancelled by the disease disappearing. It occurred to him, however, that it could be tested in a disease which, some years ago, he had experimentally proved to be specifically related to small-pox-namely, vaccinia. This investigation was carried out by Dr. Bernstein and himself on a considerable number of rabbits at the Brown Institution. The rabbit was capable of being infected with vaccinia, and it was used in the Government lymph laboratories as a routine method of testing and regenerating lymph supplies. But unfortunately the results of using salvarsan in vaccinia were absolutely negative. In some cases the inoculation was made into the marginal vein of one ear, and in others merely on the shaved skin of the back: it was not necessary to make a puncture. They waited various intervals, from six days to a few minutes only, before inoculating with salvarsan; but in no instance was the course of the eruption modified. They noticed a much greater redness of the eruption on the shaved back of the animal after salvarsan had been inoculated, probably on account' of the dilatation of the vessels. One point of interest which resulted from these experiments was that the lethal dose of the drug for the rabbit was considerably larger than previously had been realized. In cancer, as in vaccinia, his results with salvarsan had been completely negative.
Dr. GEORGE C. Low sent the following contribution: Salvarsan has now been used in quite a number of tropical diseases and in those of a spirochaetal nature the results have been quite as satisfactory as in syphilis. It has, perhaps, been most successful in the treatment of Low: Use of Salvarsan and Neo-salvarsan yaws, a disease in some ways resembling syphilis and due to the Treponerna pertenue, Castellani. First used by Strong in the Phillippines, Castellani in Ceylon, and Alston in Trinidad, the use of the drug has now been extended to many of the other Colonies, and reports from them all speak verv favourably of it. The drug has been given intramuscularly or intravenously, more so, probably, by the former method than the latter, owing to the ease of administration. Perry, in Ceylon, considers that salvarsan is an effective cure for yaws (parangi), with the possible exception of tertiary cases in which destruction of bone has occurred. He treated fifty-four cases, his dose varying from 03 to 0'6 grm., the injection being made intramuscularly or intravenously. Cockin, in Grenada, treated twenty-two cases intramuscularly, and only one case requiired a second injection, the spirochaetes disappearing from the tissues within forty-eight hours. Hughes, in St. Lucia, recommends 0'6 to 0 8 grm. In some of his cases complete cure took place in a little over a week. In one or two a second injection was required. Recurrences had not been noted when he wrote his paper, but sufficient time had not elapsed for him to make a definite statement on this point. Harper, from Fiji, and other writers, are equally enthusiastic about the drug. Summing up our knowledge of the subject, one may say that one dose of salvarsan 0 6 grm. may cure the disease; in a few cases a second or even a third dose is required. Recurrences are rare.
Relapsing Fever.-Several cases have now been treated by salvarsan. Koch, for example, has reported two in Hong Kong. The drug was given intravenously in doses of 0 5 and 0 6 grm. respectively. In both cases the parasites disappeared from the circulation within six hours and the patients rapidly recovered. The drug causes a rapid disappearance of spirochaetes of this type fronm the blood of experimental animals also.
Trypaniosomiasis.-The most extensive trial of salvarsan in the treatment of human trypanosomiasis has been made by Brodin, Rodhain and Corin, in the Belgian Congo. They used the drug either alone or in conjunction with trypaflavin, the doses given being 0 4 to 0 6 grm. Their conclusions are that the drug has a rapid and energetic action on Trypanosomia gambiense, the parasite of sleeping sickness, and a beneficial action on the patients themselves. If given early enough, they believe complete sterilization of the blood from trypanosomnes may take place, the drug acting best in the first stages of the disease, when the cerebrospinal fluid is not changed cytologically. Several of their cases relapsed, however. A case of Rhodesian trypanosomiasis, under Sir Patrick Manson's care at the Seamen's Hospital, Albert Docks, received two injections of salvarsan. The drug had no apparent effect on the trypanosomes nor on the general condition of the patient. It may be noted, however, that the patient was not in the early stages of the disease, and he had been subjected to previous treatments with atoxyl, antimony, &c. The matter is still sub judice.
Malaria.-Opinions vary as to the action of salvarsan on the plasmodia of malaria. A fairly extensive trial has now been given it, but it cannot in any way be looked upon as a specific, nor will it displace quinine. In benign forms of the disease, those due to the benign tertian parasite, Plasmodiurn vivax, or to the quartan parasite, Plas--iodium malariw, a certain amount of success has followed its use, disappearance of the parasites from the peripheral blood, fall of temperature, &c., but it has not been proved as yet to prevent relapses. In malignant forms of the disease due to the Pltasmodium falciparum the drug is not effective against the attack nor against subsequent relapses.
Leprosy.-Wellmann and others have reported cases of leprosy treated by salvarsan. The drug has practically no effect on this disease, or at least no more so than any other arsenical, acting as a general tonic, would have.
Pellagra.-Martin, in America, reviews the history of twenty-seven pellagrins who were treated by means of salvarsan. According to him, twenty of these were completely cured, three were doubtful, while four died. He believes the drug has a specific action on this malady. Niles, on the other hand, is by no means so enthusiastic about it, and states that he does not believe the drug does any good.
Tropical Ulcer.-This condition would appear to be due to a spirochaete, the Spirochwta schaudinniz. Such being the case, one would expect satisfactory results from the use of salvarsan, and reports to hand indicate that this is so.
Ulcerating Granuloma. -The drug has also been tried in this condition.
Kala-azar.-So far as I am aware no reports of salvarsan in the treatment of kala-azar have yet been published. Considering the nature and zoological affinities of the parasite it is not likely that the remedy will benefit the condition inaterially.
Filariasis.-Some cases have been reported, but whether any good accrued from the treatment cannot be definitely stated. On the whole, it is unlikely that the adult worms lying in the lymphatics will be affected, and if they are not, then the cure is useless.
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